课题基金 / 基金详情

Rapid normalization of vitamin D in critically ill children: a phase II dose evaluation randomized controlled trial (VITdAL-PICU pilot)

Rapid normalization of vitamin D in critically ill children: a phase II dose evaluation randomized controlled trial (VITdAL-PICU pilot)
危重儿童维生素 D 的快速正常化：II 期剂量评估随机对照试验（VITdAL-PICU 试点）
批准号：
351852
负责人：
McNally James D
金额：
$7.29万
依托单位：
Children's Hospital of Eastern Ontario Research Institute Inc
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-04-01 至 2017-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=351852&lang=en
关键词：
25 Hydroxyvitamin D Child Health Cholecalciferol Dose Evaluation Pediatric Critical Care Phase Ii Trial Randomized Placebo Controlled-Trial Stoss Therapy

项目摘要

项目成果

McNally James D的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Approximately 10000 children are admitted to intensive care units (ICUs) in Canada each year. These critically ill children receive costly interventions and prolonged period of rehabilitation with the goal of preventing death and reducing long-term impair
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid correction of vitamin D deficiency in pediatric critical illness: A phase III multicentre randomized controlled trial
海外基金